Genetic manipulation of LKB1 elicits lethal metastatic prostate cancer

Journal: Journal of Experimental Medicine

Published: 2020-06-01

DOI: 10.1084/jem.20191787

Affiliations: 22

Authors: 35

Go to article
Institutions Share
Center for Cooperative Research in Biosciences (CIC bioGUNE), Spain 0.19
Basque Research and Technology Alliance (BRTA), Spain 0.19
Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Spain 0.12
Institute for Research in Biomedicine (IRB Barcelona), BIST, Spain 0.08
The Institute of Cancer Research (ICR), United Kingdom (UK) 0.07
Department of Biochemistry and Molecular Biology, UPV/EHU, Spain 0.05
Departmental Section of Biochemistry and Molecular Biology I, UCM, Spain 0.04
Hospital Universitario 12 de Octubre, Spain 0.04
Unidad de Oncología Molecular, CIEMAT, Spain 0.04
Program Against Cancer Therapeutic Resistance (ProCure), IDIBELL, Spain 0.03
Department of Medicine and Animal Surgery, UCM, Spain 0.03
Department of Biochemistry and Molecular Biology, UAB, Spain 0.01
BioCruces Health Research Institute, Spain 0.01
University of the Basque Country (UPV/EHU), Spain 0.01
Institut de Neurociències (INc), UAB, Spain 0.01
Health Research Institute of San Carlos (IdISSC), Spain 0.01
The Royal Marsden NHS Foundation Trust, United Kingdom (UK) 0.01
Childhood Leukaemia Investigation Prague (CLIP), CU, Czech Republic 0.01
Department of Pediatric Hematology and Oncology, CU, Czech Republic 0.01
University Hospital in Motol, Czech Republic 0.01
Catalan Institution for Research and Advanced Studies (ICREA), Spain 0.01
Ikerbasque - Basque Foundation for Science, Spain 0

Return

Except where otherwise noted © 2021 Springer Nature Limited. All Rights Reserved.
partner of AGORA, HINARI, OARE, INASP, ORCID, CrossRef and COUNTER